None listed
Conditions
Brief summary
The Vigilance with Vital Signs Study aims to establish a system for early identification of high-risk patients through the continuous electronic monitoring of vital signs (respiratory rate, heart rate, blood pressure, skin temperature, ECG and oxygen saturation) to trigger a response and prevent adverse events in general wards. Our hypothesis is that a continuous monitoring system including clinical training, the mobile device and pre-defined alarm thresholds can reduce adverse events,deaths and unplanned admissions to intensive care by detecting earlier deterioration and prompting earlier intervention by ward staff.
Interventions
A package of activities for early detection of deterioration:
1. Two-hour Theoretical and bedside practical training sessions to ward staff individually or in small groups by an ICU hospital trainer covering interpretation of vital signs trends for earlier identification of deterioration will be delivered over a 4-week period.
2. One-week practical demonstrations by a trained facilitator in the use of a patient-worn mobile device and remote visual display for their introduc
A package of activities for early detection of deterioration: 1. Two-hour Theoretical and bedside practical training sessions to ward staff individually or in small groups by an ICU hospital trainer covering interpretation of vital signs trends for earlier identification of deterioration will be delivered over a 4-week period. 2. One-week practical demonstrations by a trained facilitator in the use of a patient-worn mobile device and remote visual display for their introduction on the wards. This will include demonstrations and practice on the technical aspects; troubleshooting; interpretation of data shown on the screen; and application of the mobile device on all consenting newly admitted patients in the target wards following a protocol. 3. Installation of hardware on nurses station for remote visual displays on the wards, and introduction of the mobile devices (recording heart rate, blood pressure, respiratory rate, oxygen saturation, skin temperature and ECG) applied to patient's wrist and chest. Each newly admitted patient to wear the mobile monitor day and night including during sleep for the first three days or until discharge if this occurs earlier. Patient recruitment over 2 years or less if sample size recruited earlier. 4. Technical support, refresher training as required and adherence monitoring by a group trained as super trainers 5. Verbal and written information provided to patients at the time of recruitment on the device purpose, instruction on alerting nurses on alarms and potential benefits of continuous monitoring Overal duration of intervention: 2-month 5 weeks clinical and technical training followed by two years of monitoring device implementation.
Sponsors
The University of New South Wales
Study design
Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
All consecutive adult patients including low-risk and high risk who are admitted to the target Neurosurgery or Respiratory Medicine wards with any diagnoses, are able to wear the device under investigation for at least the first three days from admission and can communicate in English (with or without an interpreter).
Exclusion criteria
Patients who have a Not For Resuscitation order; patients who die within 15 minutes of admission to ward; Patients who cannot communicate in English.
Outcome results
None listed